Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Published Date: 25 Dec 2024

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved progression-free survival (PFS) and ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

2.

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

3.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

4.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

5.

For treatment, the majority of cancer patients choose complementary therapies.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot